ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0479

Exploring Reproductive Experiences with Women Enrolled in the Vasculitis Pregnancy Registry

Catherine Sims1, Christine Yeung2, Heather Tam3, Joyce Kullman4, Amanda Eudy5, Renee Borchin6, Cristina Burroughs6, Megan Clowse7 and Peter Merkel2, 1Duke University School of Medicine, Durham, NC, 2University of Pennsylvania, Philadelphia, PA, 3Vasculitis Patient Powered Research Network, Stanford, CA, 4Vasculitis Foundation, Kansas City, MO, 5Duke University, Raleigh, NC, 6University of South Florida, Tampa, FL, 7Duke University, Chapel Hill, NC

Meeting: ACR Convergence 2023

Keywords: Patient reported outcomes, pregnancy, Qualitative Research, Vasculitis, Women's health

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 12, 2023

Title: (0460–0479) Reproductive Issues in Rheumatic Disorders Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: There are limited data on the reproductive health and experiences of women with vasculitis. This study engaged women with vasculitis to understand their perspectives about pregnancy and breastfeeding.

Methods: The Vasculitis Pregnancy Registry (VPREG) is an international, online, prospective, patient-reported registry within the Vasculitis Patient-Powered Research Network (VPPRN). The VPREG team partnered with the Vasculitis Foundation and patient research partners to develop two qualitative interview guides to prompt discussions of reproductive experiences with i) women who had live births; and ii) women who had non-live births. The guides included closed-ended scale items and open-ended prompts to elicit participant experiences. The interviews, performed by a rheumatologist, explored topics including pregnancy, medication choices to treat vasculitis, disease activity levels, patient-physician relationships, experiences with delivery, and breastfeeding. Participant responses were evaluated using thematic analysis.

Results: The 18 participants were located in North America, ranged in age from 25-43 years, and most had more than one pregnancy (n=11) (Table 1). Anti-neutrophil cytoplasmic antibody-associated vasculitis was the most common diagnosis (n=10) followed by Takayasu’s arteritis (n=4), Behçet’s disease (n=2), IgA vasculitis (n=1), and relapsing polychondritis (n=1). Almost all pregnancies ended in a live birth (n=17).

Four major themes emerged from interviews: 1) Women sought information about pregnancy from a range of sources, including their physicians, social media, and online forums (Figure 1); 2) Women cited discussions with family and physicians as important when deciding about treatment of vasculitis during pregnancy; 3) Women with vasculitis developed skills of self-advocacy during pregnancy to optimize communication between medical providers; and 4) Women with vasculitis had positive reproductive experiences with the majority reporting no flares of vasculitis, feeling “very well”, and having “no pain” related to their vasculitis (Figure 2). Women who required changes to their medications to pursue their reproductive goals, identified physicians and family members as important participants in these conversations. Women described proactively gathering information about pregnancy and vasculitis from multiple sources, but ultimately decided their physician’s perspective was the most influential. All women that used social media and online resources reported it did not impact or determine their reproductive decisions.

Conclusion: Women with vasculitis value the recommendations of their rheumatologists during reproductive healthcare discussions. Self-advocacy was frequently described during pregnancy because women felt they needed to act as liaisons among multiple specialists to ensure proper medical treatment. This study found that patients prioritize their relationships and conversations with physicians when planning for pregnancy.

Supporting image 1

Supporting image 2

Figure 1 displays the variety of resources patients with vasculitis accessed to gather information about their reproductive health

Supporting image 3

Figure 2 summarizes the emergent themes along the reproductive timeline of patients with vasculitis


Disclosures: C. Sims: UCB, 5; C. Yeung: None; H. Tam: None; J. Kullman: None; A. Eudy: Amgen, 2, Exagen, 5, GlaxoSmithKlein(GSK), 5, Immunovant, 5, Pfizer, 5; R. Borchin: None; C. Burroughs: None; M. Clowse: Exagen, 5, GlaxoSmithKlein(GSK), 2, 5, Immunovant, 5, UCB, 2, 5; P. Merkel: AbbVie/Abbott, 5, Amgen, 2, 5, ArGenx, 2, AstraZeneca, 2, 5, Boehringer-Ingelheim, 2, 5, Bristol-Myers Squibb(BMS), 2, 5, Cabaletta, 2, CSL Behring, 2, Eicos, 5, Electra, 5, Genentech, 5, GlaxoSmithKlein(GSK), 2, 5, HiBio, 2, InflaRx, 2, 5, Janssen, 2, Jubilant, 2, Kyverna, 2, 11, MiroBio, 2, Neutrolis, 5, Novartis, 2, NS Pharma, 2, Q32, 2, Regeneron, 2, Sanofi, 2, Sparrow, 2, Takeda, 2, 5, UpToDate, 9, Visterra, 2.

To cite this abstract in AMA style:

Sims C, Yeung C, Tam H, Kullman J, Eudy A, Borchin R, Burroughs C, Clowse M, Merkel P. Exploring Reproductive Experiences with Women Enrolled in the Vasculitis Pregnancy Registry [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/exploring-reproductive-experiences-with-women-enrolled-in-the-vasculitis-pregnancy-registry/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/exploring-reproductive-experiences-with-women-enrolled-in-the-vasculitis-pregnancy-registry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology